MiniMed reported a gross margin of 55.16% for the quarter ended Jul 2026. These financial ratios cover 5 quarters of results from Jan 2025 through Jul 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jan2025 | Apr2025 | Jan2026 | Apr2026 | Jul2026 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross Margin | 57.50% | 55.94% | 45.82% | 57.35% | 55.16% |
| EBT Margin | 3.06% | -20.44% | -12.53% | -10.99% | 0.47% |
| EBIT Margin | 3.06% | -20.44% | -12.66% | -11.11% | 0.59% |
| EBITDA Margin | 3.06% | -20.44% | -12.66% | -11.11% | 0.59% |
| Operating Margin | 3.06% | -20.44% | -12.66% | -11.11% | 0.59% |
| Net Margin | -1.02% | -23.34% | -14.05% | -22.10% | |
| FCF Margin | 3.59% | -27.00% | -10.68% | ||
| Efficiency | |||||
| Inventory AverageInventory Avg. | 359.50M | 374.50M | 348.50M | ||
| Assets AverageAssets Avg. | 4,272.00M | 4,486.50M | 4,674.00M | ||
| Equity AverageEquity Avg. | 3,615.50M | ||||
| Asset Utilization RatioAsset Util. | 0.68 | ||||
| Valuation | |||||
| Price to EarningsP/E | -20.04 | ||||
| Price to SalesP/S | 4.43 | 1.59 | |||
| Price to BookP/B | 1.03 | 1.40 | |||
| Enterprise Value | 3,408.82M | 4,871.37M | |||
| Market Capitalization | 3,706.82M | ||||
| EV to EBIT | -36.65 | ||||
| EV to EBITDA | -36.65 | ||||
| Price to FCFP/FCF | -16.40 | ||||
| EV to FCF | -15.08 | ||||
| EV to CFO | -20.05 | ||||
| Return Ratios | |||||
| Return on Sales [ROS]ROS | 3.06% | -20.44% | -12.66% | -11.11% | |
| Return on Capital Employed [ROCE]ROCE | -8.46% | ||||
| Return on Assets [ROA]ROA | -10.52% | ||||
| Return on Equity [ROE]ROE | -8.63% |